Discovery of drug response in IDH mutant gliomas with a potential to treat astrocytomas and oligodendrogliomas.
https://t.co/azSBg5XEMP
Very pleased that this has just been published in CANCER RESEARCH. Will be in Pubmed soon.
Mutant IDH sensitizes gliomas to endoplasmic reticulum stress and triggers apoptosis by MicroRNA183-mediated inhibition of Semaphorin 3E https://t.co/wdUJKAJgsZ
https://t.co/yzQWDRQysI Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades
https://t.co/yzQWDRQysI Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades: Possible new therapeutic target and biomarker.
#stem_cells_GBM_papers / #miRNA_GBM_papers:
Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades
Oncogene 2018
https://t.co/pAt6CAvDS1
Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades. https://t.co/V2qBl86pSC #Neuralstemcells
We are not changing that much actually. Of 400 tumours in our lab, we changed diagnosis on 20%. And these 400 are a 10% selection already. So, no worries we'll stick with WHO 2016 for most tumours for a while https://t.co/mINRPXrjEM